Notably, the observed activation of AMPK/mTOR pathway has been previously described for topiramate in brain tissue of APPswe/PS1dE9 transgenic model of Alzheimer’s disease as evidenced by increased phosphorylation of AMPKα [38]. This evidence concerns the gene MTOR and Alzheimer disease.